Novus Therapeutics (NVUS) Stock Price Up 5.1%
Novus Therapeutics Inc (NASDAQ:NVUS)’s share price rose 5.1% on Monday . The stock traded as high as $5.47 and last traded at $4.50. Approximately 5,457 shares were traded during trading, a decline of 98% from the average daily volume of 278,243 shares. The stock had previously closed at $4.28.
Separately, ValuEngine raised Novus Therapeutics from a “hold” rating to a “buy” rating in a report on Saturday, June 2nd.
Novus Therapeutics (NASDAQ:NVUS) last posted its quarterly earnings data on Tuesday, August 7th. The biopharmaceutical company reported ($0.34) EPS for the quarter, missing the consensus estimate of ($0.31) by ($0.03).
About Novus Therapeutics (NASDAQ:NVUS)
Novus Therapeutics, Inc, a pharmaceutical company, focuses on developing products for patients with disorders of ear, nose, and throat. Its lead product is (OP-02), a surfactant-based combination drug product for patients at risk for, or with, otitis media (OM) (middle ear inflammation with or without infection).
Featured Article: Hedge Funds
Receive News & Ratings for Novus Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novus Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.